Inhibition of both Hpse activity and the expression of tubular fibrosis markers in vitro by sulodexide furthermore highlights Hpse as a potential therapeutic target for preventing diabetic renal complications (53, 56). The gene discussed is HPSE; the disease is diabetes mellitus.